DK452089A - Anvendelse af ace-inhibitorer - Google Patents

Anvendelse af ace-inhibitorer Download PDF

Info

Publication number
DK452089A
DK452089A DK452089A DK452089A DK452089A DK 452089 A DK452089 A DK 452089A DK 452089 A DK452089 A DK 452089A DK 452089 A DK452089 A DK 452089A DK 452089 A DK452089 A DK 452089A
Authority
DK
Denmark
Prior art keywords
vessel
ace inhibitors
prevention
neointima
formation
Prior art date
Application number
DK452089A
Other languages
English (en)
Other versions
DK452089D0 (da
Inventor
Hans Rudolf Baumgartner
Jean-Paul Clozel
Fridolin Hefti
Markus Hosang
Herbert Kuhn
Rita Mueller
Jerry Powell
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK452089D0 publication Critical patent/DK452089D0/da
Publication of DK452089A publication Critical patent/DK452089A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DK452089A 1988-09-14 1989-09-13 Anvendelse af ace-inhibitorer DK452089A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH342188 1988-09-14

Publications (2)

Publication Number Publication Date
DK452089D0 DK452089D0 (da) 1989-09-13
DK452089A true DK452089A (da) 1990-03-15

Family

ID=4255625

Family Applications (1)

Application Number Title Priority Date Filing Date
DK452089A DK452089A (da) 1988-09-14 1989-09-13 Anvendelse af ace-inhibitorer

Country Status (13)

Country Link
EP (1) EP0363671B1 (da)
JP (1) JPH02121922A (da)
KR (1) KR900004337A (da)
AT (1) ATE100716T1 (da)
AU (1) AU625693B2 (da)
DE (1) DE58906814D1 (da)
DK (1) DK452089A (da)
ES (1) ES2061853T3 (da)
HU (1) HU206186B (da)
IE (1) IE892931L (da)
IL (1) IL91572A (da)
PT (1) PT91705B (da)
ZA (1) ZA896851B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3925759A1 (de) * 1989-08-03 1991-02-07 Thera Patent Verwaltungs Gmbh Verwendung von ace-inhibitoren fuer die atheroskleroseprophylaxe
DE3926606A1 (de) * 1989-08-11 1991-02-14 Hoechst Ag Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie
US5212165A (en) * 1989-10-23 1993-05-18 E. R. Squibb & Sons, Inc. Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor
US5061694A (en) * 1989-10-23 1991-10-29 E. R. Squibb & Sons, Inc. Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
US5140012A (en) * 1990-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing pravastatin
CA2042159A1 (en) * 1990-05-31 1991-12-01 Miguel A. Ondetti Method for preventing onset of restenosis after angioplasty employing an ace inhibitor
CA2052014A1 (en) * 1990-10-19 1992-04-20 Henry Y. Pan Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor
DE69500673T2 (de) 1994-05-19 1998-03-19 Mitsubishi Chem Corp Arzneimittel zur therapeutischen und prophylaktischen Behandlung von Krankheiten, die durch Hyperplasie der glatten Muskelzellen bedingt sind
JPH10508034A (ja) * 1995-03-24 1998-08-04 モレキュメティックス リミテッド βシート模倣物および生物学的に活性なペプチドまたはタンパク質のインヒビターとしてのその使用
ATE243034T1 (de) * 1996-01-17 2003-07-15 Taiho Pharmaceutical Co Ltd Intimale verdickungsinhibitoren
SI1216038T1 (sl) * 1999-08-30 2006-02-28 Sanofi Aventis Deutschland Ramipril za preprecevanje kardiovaskularnih dogodkov
JP4904859B2 (ja) * 2006-03-13 2012-03-28 大日本印刷株式会社 印刷ユニットおよびドクターブレードの研磨方法
BRPI0621867A2 (pt) * 2006-07-10 2011-12-20 Teva Pharma formulação estável que consiste na combinação de uma droga sensìvel à umidade e uma segunda droga, e processo para a sua fabricação

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105776A (en) 1976-06-21 1978-08-08 E. R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4316906A (en) 1978-08-11 1982-02-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of substituted prolines
AT377496B (de) 1981-06-19 1985-03-25 Voith Gmbh J M Vorrichtung zum anwickeln einer warenbahn auf eine neu eingelegte wickelhuelse in einer doppeltragwalzen-wickelmaschine

Also Published As

Publication number Publication date
HU206186B (en) 1992-09-28
AU4124089A (en) 1990-03-22
AU625693B2 (en) 1992-07-16
EP0363671A3 (de) 1991-12-11
PT91705A (pt) 1990-03-30
EP0363671B1 (de) 1994-01-26
IL91572A0 (en) 1990-04-29
ATE100716T1 (de) 1994-02-15
DE58906814D1 (de) 1994-03-10
IL91572A (en) 1994-01-25
JPH02121922A (ja) 1990-05-09
HUT51148A (en) 1990-04-28
ES2061853T3 (es) 1994-12-16
ZA896851B (en) 1990-06-27
EP0363671A2 (de) 1990-04-18
KR900004337A (ko) 1990-04-12
DK452089D0 (da) 1989-09-13
IE892931L (en) 1990-03-14
PT91705B (pt) 1995-05-31

Similar Documents

Publication Publication Date Title
DK452089A (da) Anvendelse af ace-inhibitorer
NO165986C (no) Roerformet proteseartikkel.
PT91863A (pt) Processo de preparacao de uma preparacao farmaceutica a base de gama-interferao
ATE253076T1 (de) Antithrombosemittel
NO985463D0 (no) Forbindelser og fremgangsmÕter for behandling eller forhindring av sykdommer av kroppspassasjeveier
DE69121704D1 (de) Kombinationskatheter zur beobachtung und zur dilatation von blutgefässen
DE69729778D1 (de) Stent zur Dilatation von stenotischen Schäden eines Blutgefässes
ATE282425T1 (de) Verfahren zur behandlung von endothelialen verletzungen
DE69222264D1 (de) Vaskularer Zugangskatheter
ATE216888T1 (de) Desferri-exochelin zur behandlung von atherosclerose und gefässbeschädigung durch verhinderung der proliferation von glatten muskelzellen
DE69224983D1 (de) Anti-wachstumsfaktor antikörper in der behandlung von gefässstenose
DK0661981T3 (da) Anvendelse af hyaluronsyre og derivater heraf til forebyggelse mod arteriel restenose
NO924637L (no) Fremgangsmaate ved forhindring av gjentilstopping av arterier
UA37249C2 (uk) Спосіб інгібування стенозу та/або рестенозу (варіанти), спосіб інгібування рестенозу після проведення операції на коронарній артерії у людини (варіанти), спосіб зниження ймовірності виникнення чи запобігання негострих ішемічних ускладнень при ангіопластиці у людини
FR2669826B1 (fr) Catheter pour la dilatation des arteres.
DK448289D0 (da) Kombineret behandling af arteria femoralis superficialis okklusion med perkutan transluminal angioplastik og lokalt indelukket rekombineret plasminogen aktivator 4 lumen eller flere lumina med 2 ellerflere balloner paa kateteret
RU93056862A (ru) Способ предотвращения рестеноза или снижения его степени
RU93015924A (ru) Способ лечения трофических язв нижних конечностей

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHB Application shelved due to non-payment